Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
REVEAL: Anacetrapib in Established Vascular Disease
NCT01252953Phase 3Active, not recruiting
- Sponsor
- University of Oxford
- Start
- Jun 2011
- Primary completion
- Jan 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of anacetrapib in atherosclerotic cardiovascular disease (ASCVD), sponsored by University of Oxford. Started Jun 2011; status: active, not recruiting.
02
Drugs
anacetrapib
03
Conditions
atherosclerotic cardiovascular disease (ASCVD)
Beyond the preview
Go deeper on NCT01252953.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01252953.